Clinical trial

Testing a Tailored Approach to Long-Term Weight Loss Success

Recruiting now · Not applicable · 1 countries · Registry ID NCT07577765

Recruiting nowNot applicableInterventional

What this study is about

The purpose of this study is to develop and test an adaptive, individually tailored intervention to prevent weight regain in people who have intentionally lost weight. The main questions it aims to answer are: * Is an adaptive intervention with tailored re-engagement support feasible for individuals following intentional weight loss? * Does this intervention prevent weight regain after intentional weight loss? Participants will: * Complete a baseline assessment of body measurements * Complete surveys on dietary intake, mental health, and physical activity Participants will also engage in a 26-week program, which involves: * Receive regular educational texts/emails * Fill out weekly online survey check-ins * Weigh themselves at least weekly on a scale provided by the study * Some participants may receive health coaching during portions of the study. * Assessments will be repeated for all participants at the end of the intervention period.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 65 Years

SexAll

Healthy volunteersAccepted

ConditionWeight Loss, Weight Regain, Obesity & Overweight

Full registry criteria

Inclusion Criteria: * BMI of ≥ 27 prior to weight loss * Lost ≥ 7% of body mass in the past 6 months * Weight loss was intentional * No plans for weight loss surgery in the next 6 months * Access to a smart device that can download applications and receive text messages * Able to receive clearance for study participation from primary care provider Exclusion Criteria: * Pregnant or within 12 months postpartum, or planning pregnancy * Uncontrolled conditions that affect overall health (cardiovascular, metabolic, renal, pulmonary, psychiatric, thyroid, cancers) * Food insecure * Bariatric surgery or cancer treatment within the past 5 years * Active or recent (\<12 months) treatment/diagnosis of an eating disorder

Treatments and study arms

Adaptive weight regain prevention

Behavioral

Adaptive intervention that will tailor participant re-engagement with professional support (e.g. health coaches) based on behavioral triggers and anthropometric monitoring (diet changes, weight increase, failure to weigh weekly).

Primary outcomes

Feasibility - Participant RetentionFrom enrollment to the end of the 26-week monitoring period

Number of participants who continue to participate for all 26 weeks of the study and complete all study activities

Feasibility - Participant AdherenceFrom enrollment to the end of the 26-week monitoring period

Number of participants who complete all study activities, including weekly weigh-ins, weekly surveys, and pre/post study visits.

Efficacy - Participant WeightFrom enrollment to the end of the 26-week monitoring period

Efficacy - Participant Dietary IntakeFrom enrollment to the end of the 26-week monitoring period

Dietary and nutritional data collected via self-report using the ASA24 (Automated Self-Administered 24-Hour Dietary Assessment Tool). This includes calories, protein, fats, and other nutrition information based on participant self-report of meals.

Efficacy - Eating Self-Efficacy in High-Risk SituationsFrom enrollment to the end of the 26-week monitoring period

Eating self-efficacy in high-risk situations will be measured pre- \& post-intervention using the Weight Efficacy Lifestyle Questionnaire.

Efficacy - Eating Behavior PatternsFrom enrollment to the end of the 26-week monitoring period

Eating behavior patterns will be measured pre- \& post-intervention using the Three-Factor Eating Questionnaire.

Efficacy - Sleep/Rest DurationFrom enrollment to the end of the 26-week monitoring period

Sleep/rest duration will be measured in hours/day using the activPAL accelerometer, a thigh-worn device that objectively measures posture and movement. Participants will wear the device continuously for 7 consecutive days.

Efficacy - Daily Step CountFrom enrollment to the end of the 26-week monitoring period

Daily step count will be measured using the activPAL accelerometer, a thigh-worn device that objectively measures posture and movement. Participants will wear the device continuously for 7 consecutive days.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

University of Utah🇺🇸 Salt Lake City, Utah, United States

Open map

Josh OliverContact

Email · Call 971-645-6693

Tanya Halliday, RD, PhDPrincipal Investigator